These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 28774281)

  • 1. Frequency of Human papillomavirus in women attending cervical cancer screening program in Chile.
    Brebi P; Ili CG; Andana A; Menzel D; Lopez J; Guzman P; Melo A; Buchegger K; Roa JC
    BMC Cancer; 2017 Aug; 17(1):518. PubMed ID: 28774281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of human papillomavirus infection among women presenting for cervical cancer screening in Chile, 2014-2015.
    Balanda M; Quiero A; Vergara N; Espinoza G; Martín HS; Rojas G; Ramírez E
    Med Microbiol Immunol; 2016 Dec; 205(6):585-594. PubMed ID: 27539577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-risk human papillomavirus diversity among indigenous women of western Botswana with normal cervical cytology and dysplasia.
    Rantshabeng PS; Tsima BM; Ndlovu AK; Motlhatlhedi K; Sharma K; Masole CB; Moraka NO; Motsumi K; Maoto-Mokote AKT; Eshetu AB; Tawe L; Gaolathe T; Moyo S; Kyokunda LT
    BMC Infect Dis; 2024 Oct; 24(1):1163. PubMed ID: 39407130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type-specific human papillomavirus prevalence in cervical intraepithelial neoplasia and cancer in Iran.
    Heydari N; Oskouee MA; Vaezi T; Shoja Z; Esmaeili HA; Hamkar R; Shahmahmoodi S; Jalilvand S
    J Med Virol; 2018 Jan; 90(1):172-176. PubMed ID: 28786495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.
    Ouh YT; Min KJ; Cho HW; Ki M; Oh JK; Shin SY; Hong JH; Lee JK
    J Gynecol Oncol; 2018 Jan; 29(1):e14. PubMed ID: 29185272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China's top 3 hospital, 2009-2019.
    Liu Y; Ang Q; Wu H; Xu J; Chen D; Zhao H; Liu H; Guo X; Gu Y; Qiu H
    Virol J; 2020 Jul; 17(1):104. PubMed ID: 32660490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotyping of human papillomavirus in cervical intraepithelial neoplasia in a high-risk population.
    Ili CG; Brebi P; López J; García P; Leal P; Suarez E; Roa JC
    J Med Virol; 2011 May; 83(5):833-7. PubMed ID: 21360550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of genotyping for management of human papillomavirus-positive, cytology-negative cervical screening results.
    Schiffman M; Burk RD; Boyle S; Raine-Bennett T; Katki HA; Gage JC; Wentzensen N; Kornegay JR; Aldrich C; Tam T; Erlich H; Apple R; Befano B; Castle PE
    J Clin Microbiol; 2015 Jan; 53(1):52-9. PubMed ID: 25339396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between human papillomavirus infection and histopathological diagnosis of women in Northeast Brazil.
    Miranda PJC; Chagas BS; Coêlho MRCD; Silva Neto JDC
    J Med Virol; 2020 Dec; 92(12):3799-3806. PubMed ID: 32989777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
    Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
    Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Performance of human papillomavirus typing test in cervical precancer lesions and cervical cancer screening].
    Zhang SK; Luo XP; Li ZF; Su Z; Xia JC; Hu GY; Zhu YJ; Xie LX; Feng XX; Sun XB; Chen W; Qiao YL
    Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):252-256. PubMed ID: 32252206
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities.
    Schmitt M; Depuydt C; Benoy I; Bogers J; Antoine J; Arbyn M; Pawlita M;
    J Clin Microbiol; 2013 May; 51(5):1458-64. PubMed ID: 23447632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical intraepithelial neoplasia across 5 countries in Asia.
    Quek SC; Lim BK; Domingo E; Soon R; Park JS; Vu TN; Tay EH; Le QT; Kim YT; Vu BQ; Cao NT; Limson G; Pham VT; Molijn A; Ramakrishnan G; Chen J
    Int J Gynecol Cancer; 2013 Jan; 23(1):148-56. PubMed ID: 23221730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18-25 years enrolled in a clinical trial.
    Zhao FH; Zhu FC; Chen W; Li J; Hu YM; Hong Y; Zhang YJ; Pan QJ; Zhu JH; Zhang X; Chen Y; Tang H; Zhang H; Durand C; Datta SK; Struyf F; Bi D;
    Int J Cancer; 2014 Dec; 135(11):2604-11. PubMed ID: 24740547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alinity m HR HPV Assay Fulfills Criteria for Human Papillomavirus Test Requirements in Cervical Cancer Screening Settings.
    Oštrbenk Valenčak A; Šterbenc A; Seme K; Poljak M
    J Clin Microbiol; 2019 Dec; 58(1):. PubMed ID: 31666369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical validation of the PCR-reverse dot blot human papillomavirus genotyping test in cervical lesions from Chinese women in the Fujian province: a hospital-based population study.
    Sun P; Song Y; Ruan G; Mao X; Kang Y; Dong B; Lin F
    J Gynecol Oncol; 2017 Sep; 28(5):e50. PubMed ID: 28657218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary cervical cancer screening and triage using an mRNA human papillomavirus assay and visual inspection.
    Nieves L; Enerson CL; Belinson S; Brainard J; Chiesa-Vottero A; Nagore N; Booth C; Pérez AG; Chávez-Avilés MN; Belinson J
    Int J Gynecol Cancer; 2013 Mar; 23(3):513-8. PubMed ID: 23334437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
    Zhao XL; Hu SY; Zhang Q; Dong L; Feng RM; Han R; Zhao FH
    J Gynecol Oncol; 2017 Jul; 28(4):e30. PubMed ID: 28541628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and type distribution of human papillomavirus in healthy Japanese women aged 20 to 25 years old enrolled in a clinical study.
    Konno R; Tamura S; Dobbelaere K; Yoshikawa H
    Cancer Sci; 2011 Apr; 102(4):877-82. PubMed ID: 21251162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of human papillomavirus genotypes among African women with normal cervical cytology and neoplasia: a systematic review and meta-analysis.
    Ogembo RK; Gona PN; Seymour AJ; Park HS; Bain PA; Maranda L; Ogembo JG
    PLoS One; 2015; 10(4):e0122488. PubMed ID: 25875167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.